SCHEMBL4394450

SCHEMBL4394450

COCOc1cc(OCOC)cc(C(C(=O)OC)c2ccccc2Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.38
CASP1 P29466 1/20 0.37
CTSA P10619 1/20 0.36
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
CYP2D6 P10635 1/20 0.35
NFKB1 P19838 1/20 0.35
HIF1A Q16665 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CLCN2 P51788 1/20 0.35
THRB P10828 1/20 0.35
NR1I2 O75469 1/20 0.35
ABCB11 O95342 1/20 0.35
CHRM2 P08172 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2B6 P20813 1/20 0.35
DRD1 P21728 1/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384096 0.79 KMT2A (0.40) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL4386704 0.78 NQO1 (0.41) KMT2AALDH1A1
SCHEMBL4382075 0.76 GAA (0.38) GRM5CYP2C19KMT2AALDH1A1
SCHEMBL4378281 0.74 MAPT (0.39) CYP2C19KMT2AALDH1A1
SCHEMBL27965733 0.74 ESR1 (0.44) CASP1ADRB2ADRB1CYP2D6NFKB1
SCHEMBL4390347 0.74 KMT2A (0.43) SMN1; SMN2KMT2AALDH1A1
SCHEMBL4389620 0.74 FYN (0.40) GRM5SMN1; SMN2KMT2A
SCHEMBL4384811 0.73 NPC1 (0.36) GRM5SMN1; SMN2CHRM2KMT2AALDH1A1
SCHEMBL4386768 0.72 FFAR1 (0.41)
SCHEMBL4379090 0.72 KDM4E (0.32) GRM5SMN1; SMN2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P GRM5 3023/4885CASP1 2868/4885CTSA 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.